Algorae Pharmaceuticals Limited [ABN: 14 104 028 042] Level 23, Rialto South Tower, 525 Collins St, Melbourne VIC 3000 P: +61 422 180 317 2026 Algorae Pharmaceuticals Limited Annual General Meeting Notice and Proxy Form Notice is hereby given that the Annual General Meeting (Meeting) of...
Algorae Pharmaceuticals: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 32 pages · English
Summary by 6ix AI
This filing is a notice for the Annual General Meeting of Algorae Pharmaceuticals Limited, detailing the meeting's agenda and proxy voting procedures. The meeting is scheduled to take place at a specified venue, and shareholders are encouraged to participate either in person or by proxy. The agenda includes the consideration of the financial report and several resolutions regarding director elections and remuneration reports. Shareholders must ensure their proxy votes are submitted by a specified deadline to be counted at the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Change of Director's Interest Notice - DH
- Date of AGM and Closing Date for Director Nominations
- Notification of cessation of securities - 1AI
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
Later from Algorae Pharmaceuticals
- Peter Mac partners with Algorae on 3rd AI validation program
- Algorae executes Licence & Supply Agreement with Umedica
- Updated Securities Trading Policy
- Quarterly Activities Report and Appendix 4C Cash Flow Report
- Corporate Presentation
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals